Le Lézard
Classified in: Health
Subjects: PER, SCZ

ComForCare Names Steven Greenbaum CEO



DETROIT, Jan. 3, 2018 /PRNewswire/ -- ComForCare Health Care Holdings LLC has named Steven Greenbaum as the home care franchisor's new CEO. Greenbaum will serve as co-CEO with ComForCare and At Your Side Home Care founder Mark Armstrong during a brief transition period, after which Armstrong will become chairman of the board.

Steven Greenbaum is the new CEO of ComForCare Health Care Holdings LLC.

ComForCare, which has 200 franchised locations in the U.S., Canada and the U.K., conducted a national search for a new CEO before selecting Greenbaum to execute its strategic growth plan. Last year, The Riverside Company invested in ComForCare to gain entry into the home care industry, a space that is experiencing significant growth. In fact, according to the U.S. Census Bureau, the number of people aged 65 and older is expected to reach 70 million by 2030, and the AARP says 87 percent of those older adults want to stay in their own homes as they age.

As founder and former CEO of PostNet, Greenbaum developed a 660-unit global printing and marketing services franchise and brings nearly 25 years of accomplishments in growing and supporting a successful franchise system. He is recognized as a thought leader and innovator throughout the franchise industry. Greenbaum is a Certified Franchise Executive, served as chairman of the International Franchise Association (IFA) in 2008 and was honored with the IFA's Entrepreneur of the Year Award in 2003. He was also featured in season four of CBS's "Undercover Boss."

"Steve brings superb credentials, with the skills to grow our franchise system and bring ComForCare's high standards for compassionate in-home care to more families and communities," said Armstrong. "As ComForCare's chairman of the board, I will continue to support the company's mission, its franchisees and our growth within the industry."

"Mark is a visionary who saw the growing need for in-home care more than 20 years ago and has well positioned ComForCare as a premier provider," said Greenbaum. "With a strong franchise system and a trusted name in home care, we believe ComForCare is poised for growth as families look to help their aging loved ones live their best life possible."

About ComForCare
ComForCare is a premier provider of in-home care with 200 independently owned and operated locations in the U.S., Canada and the U.K., helping older adults live independently in their own homes and continue to do all the things they love. The home care company is committed to helping people live their best life possible and offers special programs for people with Alzheimer's disease and other forms of dementia. ComForCare operates as At Your Side Home Care in Houston. www.comforcare.com.

About Riverside
The Riverside Company is a global private equity firm focused on making control and non-control investments in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has invested in more than 470 transactions. The firm's international portfolio includes more than 80 companies. www.riversidecompany.com/.

MEDIA CONTACT:
Pamela Hughes
24-Hour Media Line: 817-329-3257
pamela@spmcommunications.com

 

 (PRNewsfoto/ComForCare)

SOURCE ComForCare


These press releases may also interest you

13 déc 2018
Beleave Inc. ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification....

13 déc 2018
Canada House Wellness Group Inc. ("Canada House" or the "Company") is pleased to report its financial results for the three months ending October 31, 2018. All amounts are stated in thousands of Canadian dollars. Financial Highlights: Cash...

13 déc 2018
Extendicare Inc. ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of December 2018, which is payable on January 15, 2019 to shareholders of...

13 déc 2018
In the report the venous stents market, the market is expected to reach US$ $ 1,727.4 Mn in 2025 from US$ 829.0 in 2017. The market is estimated to grow with a CAGR of 9.7% from 2018-2025.Read the full report: https://www.reportlinker.com/p05653787...

13 déc 2018
The global surgical microscopes market is expected to reach US$ 1,452.4 Mn in 2025 from US$ 578.5 Mn in 2017. The surgical microscopes market is estimated to grow with a CAGR of 12.4% from 2018-2025.Read the full report:...

13 déc 2018
PEGylated Protein Therapeutics Market by Product Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple...




News published on 3 january 2018 at 15:58 and distributed by: